Beta Bionics, Inc. Common Stock (BBNX) — Financial Flexibility Index
Beta Bionics, Inc. Common Stock (BBNX) has a Financial Flexibility Index of -0.38x as of June 2026. Free cash flow of $-13.58 Million (operating CF $-14.62 Million minus capex $1.04 Million) represents 0% of total liabilities ($36.02 Million). Check Beta Bionics, Inc. Common Stock (BBNX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beta Bionics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Beta Bionics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see Beta Bionics, Inc. Common Stock (BBNX) cash conversion ratio.
Annual Financial Flexibility Index for Beta Bionics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Beta Bionics, Inc. Common Stock. Explore BBNX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.11x | $-45.63 Million | $-50.92 Million | $41.13 Million | ▼ -82.0% |
| 2024 | -0.61x | $-44.88 Million | $-48.27 Million | $73.63 Million | ▲ +2.2% |
| 2023 | -0.62x | $-32.04 Million | $-32.45 Million | $51.43 Million | ▼ -115.5% |
| 2022 | -0.29x | $-59.44 Million | $-60.21 Million | $205.56 Million | — |